cromolyn sodium has been researched along with Atherosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Secco, B; Shi, GP; Sjöberg, S; Sukhova, GK; Tia, V; Wang, J; Yang, M | 1 |
| Libby, P; Shi, GP | 1 |
2 other study(ies) available for cromolyn sodium and Atherosclerosis
| Article | Year |
|---|---|
Pharmaceutical stabilization of mast cells attenuates experimental atherogenesis in low-density lipoprotein receptor-deficient mice.
Topics: Animals; Anti-Asthmatic Agents; Atherosclerosis; Cromolyn Sodium; Disease Models, Animal; Lipoproteins, LDL; Male; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; p-Methoxy-N-methylphenethylamine; Receptors, LDL; Triglycerides; Vasculitis | 2013 |
Mast cells as mediators and modulators of atherogenesis.
Topics: Animals; Atherosclerosis; Autacoids; Cromolyn Sodium; Cytokines; Humans; Inflammation; Macrophages; Mast Cells; Mice; Models, Animal; Models, Biological; Monocytes; Peptide Hydrolases; T-Lymphocytes | 2007 |